• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Compass Diversified to sell Advanced Circuits for $220M enterprise value

Share:

January 15, 2023

Compass Diversified (NYSE:CODI) said Wednesday it will sell its majority owned unit Compass AC, the parent firm of Advanced Circuits, to printed circuit board manufacturer APCT.

Advanced Circuits will be sold for an enterprise value of $220M cash at close.

Compass (CODI) expects to realize a pre-tax gain on the sale of $100M-$110M.

Net proceeds will be used to pay off outstanding revolver borrowings.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The deal is expected to close in February.

Earlier, Compass (CODI) declared $0.25 quarterly dividend.

Source: Seeking Alpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Revolutionizing Rheumatology | Remission & Sentara’s Dynamic PartnershipRevolutionizing Rheumatology | Remission & Sentara’s Dynamic Partnership
  • Okadoc Launches Telemedicine Solution for the UAEOkadoc Launches Telemedicine Solution for the UAE
  • Capital Rx Raises $12M to Bring Transparency to Pharmacy BenefitsCapital Rx Raises $12M to Bring Transparency to Pharmacy Benefits
  • 4 ways the FDA is handling medical device cybersecurity4 ways the FDA is handling medical device cybersecurity
  • How Voice Technology Could Speed Up EHR SearchesHow Voice Technology Could Speed Up EHR Searches
  • FCC’s COVID-19 Telehealth Programs Surpasses $50M in FundingFCC’s COVID-19 Telehealth Programs Surpasses $50M in Funding
  • Supriya Lifescience Stock Technical Analysis ReportSupriya Lifescience Stock Technical Analysis Report
  • After Covid-19, Where Does the US Pharma and Biotech Industry Stand?After Covid-19, Where Does the US Pharma and Biotech Industry Stand?

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications